Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A D Koutsoukos

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Nature|May 14, 1992
Artists' offspringL V Rubinstein, A D Koutsoukos
Hematology/Oncology Clinics of North America|August 19, 2000
Quality control of oncology clinical trialsL J Meyerson, B L Wiens, L M LaVange, et al.
Cancer Research|July 15, 1994
Preclinical antitumor activity of temozolomide in mice: efficacy against human brain tumor xenografts and synergism with 1,3-bis(2-chloroethyl)-1-nitrosoureaJ Plowman, W R Waud, A D Koutsoukos, et al.
Statistics in Medicine|March 15, 1994
Discrimination techniques applied to the NCI in vitro anti-tumour drug screen: predicting biochemical mechanism of actionA D Koutsoukos, L V Rubinstein, D Faraggi, et al.
Osteoarthritis and Cartilage|April 22, 2006
An integrated analysis of five double-blind, randomized controlled trials evaluating the safety and efficacy of a hyaluronan product for intra-articular injection in osteoarthritis of the kneeV Strand, P G Conaghan, L S Lohmander, et al.
Stem Cells (Dayton, Ohio)|January 1, 1994
Predictive statistics and artificial intelligence in the U.S. National Cancer Institute's Drug Discovery Program for Cancer and AIDSJ N Weinstein, T Myers, J Buolamwini, et al.
Cancer Research|June 1, 1992
Multidrug-resistant phenotype of disease-oriented panels of human tumor cell lines used for anticancer drug screeningL Wu, A M Smythe, S F Stinson, et al.
Science (New York, N.Y.)|October 16, 1992
Neural computing in cancer drug development: predicting mechanism of actionJ N Weinstein, K W Kohn, M R Grever, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Nature|May 14, 1992
Artists' offspringL V Rubinstein, A D Koutsoukos
Hematology/Oncology Clinics of North America|August 19, 2000
Quality control of oncology clinical trialsL J Meyerson, B L Wiens, L M LaVange, et al.
Cancer Research|July 15, 1994
Preclinical antitumor activity of temozolomide in mice: efficacy against human brain tumor xenografts and synergism with 1,3-bis(2-chloroethyl)-1-nitrosoureaJ Plowman, W R Waud, A D Koutsoukos, et al.
Statistics in Medicine|March 15, 1994
Discrimination techniques applied to the NCI in vitro anti-tumour drug screen: predicting biochemical mechanism of actionA D Koutsoukos, L V Rubinstein, D Faraggi, et al.
Osteoarthritis and Cartilage|April 22, 2006
An integrated analysis of five double-blind, randomized controlled trials evaluating the safety and efficacy of a hyaluronan product for intra-articular injection in osteoarthritis of the kneeV Strand, P G Conaghan, L S Lohmander, et al.
Stem Cells (Dayton, Ohio)|January 1, 1994
Predictive statistics and artificial intelligence in the U.S. National Cancer Institute's Drug Discovery Program for Cancer and AIDSJ N Weinstein, T Myers, J Buolamwini, et al.
Cancer Research|June 1, 1992
Multidrug-resistant phenotype of disease-oriented panels of human tumor cell lines used for anticancer drug screeningL Wu, A M Smythe, S F Stinson, et al.
Science (New York, N.Y.)|October 16, 1992
Neural computing in cancer drug development: predicting mechanism of actionJ N Weinstein, K W Kohn, M R Grever, et al.
Pageof 1